{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T16:26:54Z","timestamp":1792945614547,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T00:00:00Z","timestamp":1508112000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00259-017-3854-6","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T08:25:55Z","timestamp":1508142355000},"page":"340-347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Simultaneous whole-body 18F\u2013PSMA-1007-PET\/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot study"],"prefix":"10.1007","volume":"45","author":[{"given":"Martin T.","family":"Freitag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Cardinale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Flechsig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Floca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bonekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"Radtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Kratochwil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kopka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hohenfellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrecht","family":"Stenzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Peter","family":"Schlemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Haberkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Giesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,16]]},"reference":[{"key":"3854_CR1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00259-014-2949-6","volume":"42","author":"A Afshar-Oromieh","year":"2015","unstructured":"Afshar-Oromieh A, Avtzi E, Giesel FL, Holland-Letz T, Linhart HG, Eder M, et al. The diagnostic value of PET\/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2015;42:197\u2013209.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3854_CR2","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2967\/jnumed.115.154153","volume":"56","author":"M Eiber","year":"2015","unstructured":"Eiber M, Maurer T, Souvatzoglou M, Beer AJ, Ruffani A, Haller B, et al. Evaluation of hybrid 68Ga-PSMA-ligand PET\/CT in 248 patients with biochemical recurrence after radical prostatectomy. J Nucl Med. 2015;56:668\u201374.","journal-title":"J Nucl Med"},{"key":"3854_CR3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/bc200279b","volume":"23","author":"M Eder","year":"2012","unstructured":"Eder M, Sch\u00e4fer M, Bauder-W\u00fcst U, Hull W-E, W\u00e4ngler C, Mier W, et al. 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging. Bioconjug Chem. 2012;23:688\u201397.","journal-title":"Bioconjug Chem"},{"key":"3854_CR4","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1158\/1078-0432.CCR-04-2690","volume":"11","author":"CA Foss","year":"2005","unstructured":"Foss CA, Mease RC, Fan H, Wang Y, Ravert HT, Dannals RF, et al. Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11:4022\u20138.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"3854_CR5","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1158\/1078-0432.CCR-07-1517","volume":"14","author":"RC Mease","year":"2008","unstructured":"Mease RC, Dusich CL, Foss CA, Ravert HT, Dannals RF, Seidel J, et al. N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2008;14:3036\u201343.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"3854_CR6","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1158\/1078-0432.CCR-11-1357","volume":"17","author":"Y Chen","year":"2011","unstructured":"Chen Y, Pullambhatla M, Foss CA, Byun Y, Nimmagadda S, Senthamizhchelvan S, et al. 2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2011;17:7645\u201353.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"3854_CR7","first-page":"1003","volume":"56","author":"SP Rowe","year":"2015","unstructured":"Rowe SP, Gage KL, Faraj SF, Macura KJ, Cornish TC, Gonzalez-Roibon N, et al. 18F-DCFBC PET\/CT for PSMA-based detection and characterization of primary prostate cancer. J Nucl Med Off Publ Soc Nucl Med. 2015;56:1003\u201310.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"3854_CR8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11307-015-0850-8","volume":"17","author":"Z Szabo","year":"2015","unstructured":"Szabo Z, Mena E, Rowe SP, Plyku D, Nidal R, Eisenberger MA, et al. Initial evaluation of [(18)F]DCFPyL for prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer. Mol Imaging Biol MIB Off Publ Acad Mol Imaging. 2015;17:565\u201374.","journal-title":"Mol Imaging Biol MIB Off Publ Acad Mol Imaging"},{"key":"3854_CR9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2967\/jnumed.116.181768","volume":"58","author":"J Cardinale","year":"2017","unstructured":"Cardinale J, Schafer M, Bene\u0161ova M, Bauder-Wust U, Leotta K, Eder M, et al. Preclinical evaluation of [18F]PSMA-1007: a new PSMA-ligand for prostate cancer imaging. J Nucl Med. 2017;58:425\u201331.","journal-title":"J Nucl Med"},{"key":"3854_CR10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","volume":"44","author":"FL Giesel","year":"2017","unstructured":"Giesel FL, Hadaschik B, Cardinale J, Radtke J, Vinsensia M, Lehnert W, et al. F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients. Eur J Nucl Med Mol Imaging. 2017;44:678\u201388.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3854_CR11","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s00259-016-3594-z","volume":"44","author":"MT Freitag","year":"2017","unstructured":"Freitag MT, Radtke JP, Afshar-Oromieh A, Roethke MC, Hadaschik BA, Gleave M, et al. Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in (68)Ga-PSMA-11-PET of PET\/CT and PET\/MRI: comparison with mpMRI integrated in simultaneous PET\/MRI. Eur J Nucl Med Mol Imaging. 2017;44:776\u201387.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3854_CR12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00259-013-2660-z","volume":"41","author":"A Afshar-Oromieh","year":"2014","unstructured":"Afshar-Oromieh A, Haberkorn U, Schlemmer HP, Fenchel M, Eder M, Eisenhut M, et al. Comparison of PET\/CT and PET\/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience. Eur J Nucl Med Mol Imaging. 2014;41:887\u201397.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3854_CR13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.eururo.2015.12.053","volume":"70","author":"M Eiber","year":"2016","unstructured":"Eiber M, Weirich G, Holzapfel K, Souvatzoglou M, Haller B, Rauscher I, et al. Simultaneous 68Ga-PSMA HBED-CC PET\/MRI improves the localization of primary prostate cancer. Eur Urol. 2016;70:829\u201336.","journal-title":"Eur Urol"},{"key":"3854_CR14","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s00259-015-3206-3","volume":"43","author":"MT Freitag","year":"2016","unstructured":"Freitag MT, Radtke JP, Hadaschik BA, Kopp-Schneider A, Eder M, Kopka K, et al. Comparison of hybrid (68)Ga-PSMA PET\/MRI and (68)Ga-PSMA PET\/CT in the evaluation of lymph node and bone metastases of prostate cancer. Eur J Nucl Med Mol Imaging. 2016;43:70\u201383.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3854_CR15","doi-asserted-by":"crossref","unstructured":"Freitag MT, Fenchel M, B\u00e4umer P, Heu\u00dfer T, Rank CM, Kachelrie\u00df M, et al. Improved clinical workflow for simultaneous whole-body PET\/MRI using high-resolution CAIPIRINHA-accelerated MR-based attenuation correction. Eur J Radiol. 2017;96:12\u201320.","DOI":"10.1016\/j.ejrad.2017.09.007"},{"key":"3854_CR16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","volume":"69","author":"JC Weinreb","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, et al. PI-RADS prostate imaging \u2013 reporting and data system: 2015, version 2. Eur Urol. 2016;69:16\u201340.","journal-title":"Eur Urol"},{"key":"3854_CR17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1102\/1470-7330.2008.0018","volume":"8","author":"J Biederer","year":"2008","unstructured":"Biederer J. MRI of pulmonary nodules: technique and diagnostic value. Cancer Imaging. 2008;8:125\u201330.","journal-title":"Cancer Imaging"},{"key":"3854_CR18","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.5489\/cuaj.10136","volume":"5","author":"CJD Wallis","year":"2011","unstructured":"Wallis CJD, English JC, Goldenberg SL. The role of resection of pulmonary metastases from prostate cancer: a case report and literature review. Can Urol Assoc J. 2011;5:e104\u20138.","journal-title":"Can Urol Assoc J"},{"key":"3854_CR19","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.juro.2013.05.021","volume":"190","author":"DM Somford","year":"2013","unstructured":"Somford DM, Hamoen EH, F\u00fctterer JJ, van Basten JP, Hulsbergen-van de Kaa CA, Vreuls W, et al. The predictive value of endorectal 3 tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer. J Urol. 2013;190:1728\u201334.","journal-title":"J Urol"},{"key":"3854_CR20","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1089\/end.2015.0358","volume":"29","author":"JP Radtke","year":"2015","unstructured":"Radtke JP, Hadaschik BA, Wolf MB, Freitag MT, Schwab C, Alt C, et al. The impact of magnetic resonance imaging on prediction of extraprostatic extension and prostatectomy outcome in patients with low-, intermediate- and high-risk prostate cancer: try to find a standard. J Endourol. 2015;29:1396\u2013405.","journal-title":"J Endourol"},{"key":"3854_CR21","doi-asserted-by":"crossref","unstructured":"Koerber SA, Utzinger MT, Kratochwil C, Kesch C, Haefner M, Katayama S, et al. (68)Ga-PSMA11-PET\/CT in newly diagnosed carcinoma of the prostate: correlation of intraprostatic PSMA uptake with several clinical parameters. J Nucl Med Off Publ Soc Nucl Med. 2017.","DOI":"10.2967\/jnumed.117.190314"},{"key":"3854_CR22","volume-title":"Table of isotopes","year":"1978","unstructured":"Lederer CM, Shirley VS, Browne E, editors. Table of isotopes. 7th ed. New York: Wiley; 1978.","edition":"7"},{"key":"3854_CR23","doi-asserted-by":"crossref","unstructured":"Hong I, Rothfuss H, F\u00fcrst S, Michel C, Nekolla SG, Bendriem B, et al. Prompt gamma correction for Ga-68 PSMA PET studies. IEEE Xplore [Internet]. 2015; Available from: http:\/\/ieeexplore.ieee.org\/stamp\/stamp.jsp?arnumber=7582166 . Accessed 2017\u201304-02.","DOI":"10.1109\/NSSMIC.2015.7582166"},{"key":"3854_CR24","doi-asserted-by":"crossref","first-page":"e0183329","DOI":"10.1371\/journal.pone.0183329","volume":"12","author":"T Heu\u00dfer","year":"2017","unstructured":"Heu\u00dfer T, Mann P, Rank CM, Sch\u00e4fer M, Dimitrakopoulou-Strauss A, Schlemmer H-P, et al. Investigation of the halo-artifact in 68Ga-PSMA-11-PET\/MRI. PLoS One. 2017;12:e0183329.","journal-title":"PLoS One"},{"key":"3854_CR25","doi-asserted-by":"crossref","unstructured":"Afshar-Oromieh A, Wolf M, Haberkorn U, Kachelrie\u00df M, Gnirs R, Kopka K, et al. Effects of arm truncation on the appearance of the halo artifact in 68Ga-PSMA-11 (HBED-CC) PET\/MRI. Eur J Nucl Med Mol Imaging. 2017.","DOI":"10.1007\/s00259-017-3718-0"},{"key":"3854_CR26","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/mrm.24555","volume":"70","author":"JO Blumhagen","year":"2013","unstructured":"Blumhagen JO, Ladebeck R, Fenchel M, Scheffler K. MR-based field-of-view extension in MR\/PET: B0 homogenization using gradient enhancement (HUGE). Magn Reson Med. 2013;70:1047\u201357.","journal-title":"Magn Reson Med"},{"key":"3854_CR27","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1088\/1361-6560\/aa7a8c","volume":"62","author":"A Rezaei","year":"2017","unstructured":"Rezaei A, Salvo K, Vahle T, Panin V, Casey M, Boada F, et al. Plane-dependent ML scatter scaling: 3D extension of the 2D simulated single scatter (SSS) estimate. Phys Med Biol. 2017;62:6515\u201331.","journal-title":"Phys Med Biol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-017-3854-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3854-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3854-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T18:31:01Z","timestamp":1570213861000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-017-3854-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,16]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3854"],"URL":"https:\/\/doi.org\/10.1007\/s00259-017-3854-6","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,16]]}}}